Limits to anti-nausea pill coverage wear on cancer patients and doctors
Some cancer patients are hitting coverage limits on a cheap anti-nausea pill that can ward off waves of vomiting after treatment. Doctors say restrictions on the number of tablets can hurt care. Pharmacy benefit managers say their restrictions guard against overuse. In between sits patients. They may have to ration pills or opt for less-effective help. The conflict offers a glimpse at how relatively simple acts of care can grow complex in the fragmented U.S. health care system.